Uncategorized

In NIH-Cosponsored Monkeypox Virus Study In Congo, SIGA Technologies’ Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks – Yahoo Finance

Posted on Author Comments Off on In NIH-Cosponsored Monkeypox Virus Study In Congo, SIGA Technologies’ Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks – Yahoo Finance

In NIH-Cosponsored Monkeypox Virus Study In Congo, SIGA Technologies’ Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks  Yahoo FinanceThe antiviral tecovirimat is safe but did not improve clade I mpox resolution in Democratic Republic of the Congo  National Institutes of Health (NIH) (.gov)Antiviral used for mpox no better than placebo, NIH says  STATSIGA Technologies Shares Slide Premarket as Mpox Study Disappoints  MarketWatchAs mpox outbreak spreads across Africa, Siga’s antiviral Tpoxx misses the bar in Congo study  FiercePharma